Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker(Brigham and Women's Hospital), Jean MacFadyen(Brigham and Women's Hospital), Brendan M Everett(Brigham and Women's Hospital), Peter Libby(Brigham and Women's Hospital), Tom Thurén(Novartis (Switzerland)), Robert J. Glynn(Brigham and Women's Hospital), Paul M. Ridker(Brigham and Women's Hospital), Jean MacFadyen(Brigham and Women's Hospital), Brendan M Everett(Brigham and Women's Hospital), Peter Libby(Brigham and Women's Hospital), Tom Thurén(Novartis (Switzerland)), Robert J. Glynn(Brigham and Women's Hospital), John J.P. Kastelein, Wolfgang Köenig, Jacques Genest, Alberto Lorenzatti, George Varigos, Peter Siostrzonek(Brigham and Women's Hospital), Peter Sinnaeve(Brigham and Women's Hospital), Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Les B. Forgosh, Barry Harris, M Ligueros
Cited by 876Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis